greeksoup/ stock research

Bruker (BRKR) FY2023 results: revenue $3.0 billion, up 17.1% on the year

Bruker Corp. (BRKR) reported revenue of $3.0 billion for fiscal 2023, the year ended 31 December 2023, up 17.1% on the year before. Net income was $427 million, up 44.0%, and diluted earnings per share $2.90. The figures are the company's own, from the 10-K it filed with the SEC on 29 February 2024.

Revenue
$3.0 billion
+17.1% on the year
FY2016FY2023
Operating margin
14.7%
17.1% a year earlier
FY2016FY2023
Net income
$427 million
+44.0% on the year
FY2016FY2023
Diluted EPS
$2.90
+45.7% on the year
FY2016FY2023

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2023 · Q2 FY2023 · Q3 FY2023 · Q4 FY2023

Income statement (profit and loss)

$ millionFY2023FY2022FY2021On the yearLast 8 years
Revenue2,9642,5312,418+17.1%
Cost of revenue1,4511,2251,208+18.5%
Gross profit1,5131,3061,210+15.9%
Gross margin51.0%51.6%50.0%
Research and development295236221+25.0%
Selling, general and administrative729607561+20.1%
Operating income437433413+1.0%
Operating margin14.7%17.1%17.1%
Interest expense16.416.114.3+1.9%
Pre-tax income544414394+31.5%
Income tax118116113+1.1%
Effective tax rate21.6%28.1%28.7%
Net income427297277+44.0%
Net margin14.4%11.7%11.5%
Diluted EPS$2.90$1.99$1.81+45.7%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2023FY2022FY2021On the yearLast 8 years
Operating cash flow350274282+27.6%
Capital expenditure10712992.0-17.3%
Free cash flow243145190+67.5%
Free cash flow margin8.2%5.7%7.9%
Cash from investing-326-252-192
Cash from financing-193-415319
Depreciation and amortisation11588.889.1+29.4%
Share-based compensation30.927.717.2+11.6%
Buybacks152263153-42.1%
Dividends paid29.429.824.2-1.3%
Dividend per share$0.20$0.16$0.16+25.0%
Diluted shares, weighted147m149m153m-1.5%
Shares outstanding at period end145m147m151m-1.3%

Balance sheet

$ millionFY2023FY2022FY2021On the yearLast 8 years
Shareholders' equity1,3771,1141,070+23.6%
Non-controlling interest17.411.914.1+46.2%
Redeemable equity18.76.10.2+206.6%
Debt1,2821,2191,334+5.1%
Operating lease liabilities74.834.841.8+114.9%
Finance lease liabilities15.811.72.6+35.0%
Other liabilities1,4641,2141,187+20.6%
Total liabilities and equity4,2503,6123,650+17.7%
Fixed assets600487406+23.1%
Goodwill583458340+27.3%
Intangible assets330271212+22.0%
Investmentsn/a0.0100
Cash and equivalents4886461,068-24.4%
Receivables492473417+4.1%
Inventory968800710+21.0%
Other assets788478397+65.0%
Total assets4,2503,6123,650+17.7%

10-K for the year ended 31 December 2023, filed 29 February 2024: the filing.